Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$72.15
1.011.42%
Pre-Market: 8:12 AM EDT
15 minutes delayed
Comments
Loading...
Biomarin Pharmaceutical (BMRN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Biomarin Pharmaceutical (NASDAQ:BMRN) Stock Quotes, Forecast and News Summary
Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 49.70K / 2.22M |
| Day Range | - - - |
| 52 Wk Range | 68.83 - 99.56 |
| Market Cap | $13.74B |
| P/E Ratio | 53.89 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 3.09% |
| Days to Cover | 4.1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Biomarin Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture ...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Biomarin Pharmaceutical (BMRN) stock?
You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Who are Biomarin Pharmaceutical (BMRN) competitors?
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Biomarin Pharmaceutical (BMRN) stock?
Biomarin Pharmaceutical has a consensus price target of $104.08.
What is the current price for Biomarin Pharmaceutical (BMRN)?
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $72.15 last updated September 19, 2024 at 8:12 AM EDT.
Does Biomarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for Biomarin Pharmaceutical.
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Biomarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for Biomarin Pharmaceutical.
What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.